Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-05-29 @ 5:08 AM
Study NCT ID:
NCT05634369
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2022-11-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue
Sponsor:
Nationwide Children's Hospital
Organization: